• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant and .基于1,3 - 二芳基取代吡唑的(硫)脲衍生物作为抗多药耐药菌的强效抗菌剂的合成及药理学评价
RSC Med Chem. 2023 May 10;14(7):1296-1308. doi: 10.1039/d3md00079f. eCollection 2023 Jul 20.
2
Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.新型喹唑啉-4(3H)-酮衍生物的合成与评价,作为抗多药耐药金黄色葡萄球菌和结核分枝杆菌的有效抗菌剂。
Eur J Med Chem. 2019 Aug 1;175:287-308. doi: 10.1016/j.ejmech.2019.04.067. Epub 2019 Apr 28.
3
Synthesis and biological evaluation of new naphthalimide-thiourea derivatives as potent antimicrobial agents active against multidrug-resistant and .新型萘二甲酰亚胺-硫脲衍生物作为抗多重耐药菌的强效抗菌剂的合成及生物学评价
RSC Med Chem. 2024 Mar 19;15(4):1381-1391. doi: 10.1039/d4md00062e. eCollection 2024 Apr 24.
4
Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents.合成、生物筛选及新型 N-苯基-4-(1,3-二芳基-1H-吡唑-4-基)噻唑-2-胺衍生物的计算机辅助研究作为潜在的抗真菌和抗结核药物。
Eur J Med Chem. 2023 Oct 5;258:115548. doi: 10.1016/j.ejmech.2023.115548. Epub 2023 Jun 7.
5
Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.新型席夫碱连接吡唑部分的发现:作为具有免疫调节活性的双重靶向 DHFR/DNA 拓扑异构酶抑制剂的设计、合成、生物评价和分子对接研究。
Molecules. 2020 Jun 2;25(11):2593. doi: 10.3390/molecules25112593.
6
Exploring the potential of bis(thiazol-5-yl)phenylmethane derivatives as novel candidates against genetically defined multidrug-resistant Staphylococcus aureus.探索双(噻唑-5-基)苯甲烷衍生物作为新型候选药物对抗基因定义的耐多药金黄色葡萄球菌的潜力。
PLoS One. 2024 Mar 22;19(3):e0300380. doi: 10.1371/journal.pone.0300380. eCollection 2024.
7
Bio-evaluation of fluoro and trifluoromethyl-substituted salicylanilides against multidrug-resistant .含氟和三氟甲基取代水杨酰苯胺对多重耐药菌的生物学评价
Med Chem Res. 2021;30(12):2301-2315. doi: 10.1007/s00044-021-02808-4. Epub 2021 Oct 27.
8
Synthesis and antibacterial evaluation of (E)-1-(1H-indol-3-yl) ethanone O-benzyl oxime derivatives against MRSA and VRSA strains.(E)-1-(1H-吲哚-3-基)乙酮 O-苄基肟衍生物的合成及对 MRSA 和 VRSA 菌株的抗菌活性评价。
Bioorg Chem. 2021 Nov;116:105288. doi: 10.1016/j.bioorg.2021.105288. Epub 2021 Aug 19.
9
A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and -VRSA.让无效抗生素重新用于治疗的希望:研究蜂毒肽单独以及与青霉素和苯唑西林联合使用对多重耐药性耐甲氧西林金黄色葡萄球菌(MRSA)和耐万古霉素金黄色葡萄球菌(VRSA)的抗生物膜潜力。
Front Microbiol. 2024 Feb 1;14:1269392. doi: 10.3389/fmicb.2023.1269392. eCollection 2023.
10
Design, synthesis and antibacterial evaluation of pleuromutilin derivatives.截短侧耳素衍生物的设计、合成及抗菌活性评价
Bioorg Med Chem. 2022 Apr 1;59:116676. doi: 10.1016/j.bmc.2022.116676. Epub 2022 Feb 23.

引用本文的文献

1
A diaryl urea derivative, SMCl inhibits cell proliferation through the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma.一种二芳基脲衍生物SMCl通过RAS/RAF/MEK/ERK途径抑制肝癌细胞增殖。
Front Pharmacol. 2025 Jul 10;16:1605515. doi: 10.3389/fphar.2025.1605515. eCollection 2025.
2
Design, synthesis, and biological evaluation of pyrazole-ciprofloxacin hybrids as antibacterial and antibiofilm agents against .作为针对……的抗菌和抗生物膜剂的吡唑-环丙沙星杂化物的设计、合成及生物学评价
RSC Med Chem. 2024 Oct 22;16(1):420-8. doi: 10.1039/d4md00623b.
3
On-demand imidazolidinyl urea-based tissue-like, self-healable, and antibacterial hydrogels for infectious wound care.用于感染性伤口护理的按需制备的基于咪唑烷基脲的组织样、可自愈且抗菌的水凝胶。
Bioact Mater. 2024 Oct 15;44:116-130. doi: 10.1016/j.bioactmat.2024.10.003. eCollection 2025 Feb.
4
New Pyrazolyl Thioureas Active against the Genus.对该属有效的新型吡唑基硫脲
Pharmaceuticals (Basel). 2024 Mar 15;17(3):376. doi: 10.3390/ph17030376.

本文引用的文献

1
Synthesis, biological evaluation and computational studies of pyrazole derivatives as CYP121A1 inhibitors.作为CYP121A1抑制剂的吡唑衍生物的合成、生物学评价及计算研究
RSC Med Chem. 2022 Aug 16;13(11):1350-1360. doi: 10.1039/d2md00155a. eCollection 2022 Nov 16.
2
Isoxazole carboxylic acid methyl ester-based urea and thiourea derivatives as promising antitubercular agents.基于异恶唑羧酸甲酯的脲和硫脲衍生物作为有前途的抗结核药物。
Mol Divers. 2023 Oct;27(5):2037-2052. doi: 10.1007/s11030-022-10543-0. Epub 2022 Oct 25.
3
Synthesis and biological evaluation of novel N, N'-diarylurea derivatives as potent antibacterial agents against MRSA.新型 N,N'-二芳基脲衍生物的合成及作为抗耐甲氧西林金黄色葡萄球菌(MRSA)的有效抗菌剂的生物评价。
Bioorg Med Chem Lett. 2022 Nov 1;75:128975. doi: 10.1016/j.bmcl.2022.128975. Epub 2022 Sep 5.
4
Synthesis of a new series of quinoline/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors.合成一系列新型喹啉/吡啶吲哚-3-磺酰胺杂合体作为选择性碳酸酐酶 IX 抑制剂。
Bioorg Med Chem Lett. 2022 Aug 15;70:128809. doi: 10.1016/j.bmcl.2022.128809. Epub 2022 May 21.
5
Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.鉴定硝呋尔酮查耳酮键合苯并恶唑-2-胺作为潜在的耐药结核分枝杆菌抑制剂,具有杀菌功效。
Bioorg Med Chem. 2022 Jun 15;64:116777. doi: 10.1016/j.bmc.2022.116777. Epub 2022 Apr 23.
6
Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens.新型含吡唑并噻唑-4-酮/噻吩衍生物作为双靶点DNA促旋酶和二氢叶酸还原酶抑制剂对多重耐药病原体的抗菌评价、单点耐药性研究及辐射灭菌
ACS Omega. 2022 Feb 3;7(6):4970-4990. doi: 10.1021/acsomega.1c05801. eCollection 2022 Feb 15.
7
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
8
Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores.选择性DNA回旋酶抑制剂:基于3D药效团的多靶点计算机模拟分析
Pharmaceuticals (Basel). 2021 Aug 10;14(8):789. doi: 10.3390/ph14080789.
9
Synthesis of Antimicrobial Benzimidazole-Pyrazole Compounds and Their Biological Activities.抗菌苯并咪唑 - 吡唑化合物的合成及其生物活性
Antibiotics (Basel). 2021 Aug 19;10(8):1002. doi: 10.3390/antibiotics10081002.
10
Drug metabolic stability in early drug discovery to develop potential lead compounds.在早期药物发现中开发有潜力的先导化合物时,药物代谢稳定性。
Drug Metab Rev. 2021 Aug;53(3):459-477. doi: 10.1080/03602532.2021.1970178. Epub 2021 Sep 11.

基于1,3 - 二芳基取代吡唑的(硫)脲衍生物作为抗多药耐药菌的强效抗菌剂的合成及药理学评价

Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant and .

作者信息

Ommi Ojaswitha, Naiyaz Ahmad Mohammad, Gajula Siva Nageswara Rao, Wanjari Parita, Sau Shashikanta, Agnivesh Puja Kumari, Sahoo Santosh Kumar, Kalia Nitin Pal, Sonti Rajesh, Nanduri Srinivas, Dasgupta Arunava, Chopra Sidharth, Yaddanapudi Venkata Madhavi

机构信息

Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER) Balanagar Hyderabad 500037 Telangana India

Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute Sector 10, Jankipuram Extension, Sitapur Road Lucknow 226031 UP India.

出版信息

RSC Med Chem. 2023 May 10;14(7):1296-1308. doi: 10.1039/d3md00079f. eCollection 2023 Jul 20.

DOI:10.1039/d3md00079f
PMID:37484564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10357928/
Abstract

The urgent development of newer alternatives has been deemed a panacea for tackling emerging antimicrobial resistance effectively. Herein, we report the design, synthesis, and biological evaluation of 1,3-diaryl substituted pyrazole-based urea and thiourea derivatives as antimicrobial agents. Preliminary screening results revealed that compound 7a (3,4-dichlorophenyl derivative) exhibited potent activity against (MIC = 0.25 μg mL) and compound 7j (2,4-difluorophenyl derivative) against (MIC = 1 μg mL). Compounds 7a and 7j were non-toxic to Vero cells with a favorable selectivity index of 40 and 200, respectively, and demonstrated good microsomal stability. Compound 7a exhibited equipotent activity (MIC = 0.25 μg mL) against various multidrug-resistant strains of , which include various strains of MRSA and VRSA, and elicited bacteriostatic properties. In an enzymatic assay, 7a effectively inhibited DNA gyrase supercoiling activity at a concentration of 8 times MIC. Further, molecular modeling studies suggested that compound 7a binds at the active site of DNA gyrase with good affinity.

摘要

开发更新的替代物的紧迫性被视为有效应对新出现的抗菌药物耐药性的万灵药。在此,我们报告了作为抗菌剂的1,3 - 二芳基取代吡唑基脲和硫脲衍生物的设计、合成及生物学评价。初步筛选结果表明,化合物7a(3,4 - 二氯苯基衍生物)对[具体菌株未提及]表现出强效活性(MIC = 0.25 μg/mL),化合物7j(2,4 - 二氟苯基衍生物)对[具体菌株未提及]表现出强效活性(MIC = 1 μg/mL)。化合物7a和7j对Vero细胞无毒,选择性指数分别为40和200,显示出良好的微粒体稳定性。化合物7a对包括各种耐甲氧西林金黄色葡萄球菌(MRSA)和耐万古霉素金黄色葡萄球菌(VRSA)菌株在内的各种多重耐药[具体菌株未提及]菌株表现出同等效力的活性(MIC = 0.25 μg/mL),并具有抑菌特性。在酶促试验中,7a在8倍MIC浓度下有效抑制DNA促旋酶超螺旋活性。此外,分子模拟研究表明化合物7a以良好的亲和力结合于DNA促旋酶的活性位点。